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Obesity and high body mass index (BMI) are known to be risks for anovulation and infertility. Little is 
known about how BMI levels affect parameters of the menstrual cycle. The purpose of this study was 
to determine the influence of BMI on parameters of the menstrual cycle and the likelihood for 
ovulation. The participants in this study were 244 women between the ages of twenty and fifty-four 
(mean thirty years) who charted from one to thirty-six menstrual cycles (mean seven cycles) for a total 
of 2,035 cycles. Urinary luteinizing hormone (LH) threshold tests were used to estimate the day of 
ovulation and the lengths of the follicular and luteal phases. The 244 participants were classified as 
normal weight with a BMI of 18.5–24.9 kg/m2 (N = 141), overweight with a BMI of 25–29.9 kg/m2 (N = 
67), and obese with a BMI of 30 kg/m2 or greater (N = 36). One-way ANOVA indicated that there was a 
significant difference between groups in length of the luteal phase (F = 4.62, p < 0.01) and length of 
menses (F = 3.03, p < 0.05). Odds ratio indicated that the combined obese and overweight group was 
34 percent less likely to have a positive detected urinary LH surge. We concluded that obesity might 
contribute to infertility by shortening the luteal phase and decreasing the probability of ovulatory 
menstrual cycles. 
Introduction 
Obesity is a growing worldwide epidemic. According to the World Health Organization in 2008, over 1.4 
billion adults, twenty and older, were overweight. This included 200 million men and almost 300 
million women who were considered to be obese with a body mass index (BMI) over 30 kg/m2.1 Data 
from the National Health and Nutrition Examination Survey show that from 2009 through 2010, obese 
men made up 35.5 percent and obese women comprised 35.8 percent of people in the United States 
alone.2 The number of chronic diseases related to obesity is extensive with obesity being a risk factor 
for cardiovascular disease, hypertension, non-insulin dependent diabetes, dyslipidemia, arthritis, and 
some cancers. In addition to these co-morbidities, obesity has long been thought to affect women's 
reproductive health. In fact, much research has been performed focusing on the relationship between 
body weight and fertility in women with many studies showing links between obesity and infertility. 
Furthermore, there is some evidence that body weight influences the functioning of the menstrual 
cycle. Obese women have been found to have irregular menstrual cycles with increased incidences of 
oligomenorrhea or amenorrhea.3 Irregularities in ovulation have also been demonstrated,4 and obese 
women have higher rates of miscarriages.5 However, there is very little evidence regarding the 
influence that BMI has on the characteristics (or phases) of the menstrual cycle. Therefore, the 
purpose of this study was to evaluate the influence of BMI levels on the phases of the menstrual cycle, 
i.e., the length of the overall cycle, the length of the follicular and luteal phases, menses, and the 
likelihood of ovulation. A secondary purpose was to speculate if obesity has an effect on the ability to 
achieve pregnancy and whether alterations in luteal function play a role in this effect. 
Materials and Methods 
Study Design 
This was a retrospective study of 234 women who prospectively self-monitored their menstrual cycles 
for fertility parameters and who contributed fertility and menstrual data to an online registry 
throughout metropolitan Milwaukee between 2008 and 2012 for general research purposes. 
Participants were self-chosen to participate in data collection. Data collected represented 2,035 
menstrual cycles with one to thirty-six menstrual cycles per subject (mean 7.2, SD = 5.9). The study was 
approved by the Marquette University Institutional Review Board and participants provided informed 
consent prior to providing data to the registry. The participants were registered in an online natural 
family planning website hosted by the Marquette University Institute for Natural Family Planning. Data 
was made available to the authors through the Marquette University Institute for Natural Family 
Planning. Data in the registry involved forty-nine variables including age of the participant and spouse, 
menstrual cycle parameters, height, weight, BMI, and pregnancy history. For this study, age, BMI, 
gravidity, parity, length of menstrual cycle, length of follicular phase, estimated day of ovulation based 
on urine luteinizing hormone (LH) threshold self-test, and length of menses were evaluated. 
Definitions of Dependent (Outcome) Variables 
Length of menstrual cycle was counted from the first day of recorded menses up to and including the 
day before the next menses. 
Length of follicular phase of the menstrual cycle was counted from the first day of recorded menses up 
to and including the day after the positive urinary threshold surge. 
Length of luteal phase of the menstrual cycle was counted from the day after the positive urinary LH 
test up to and including the day before the next menses. The menstrual cycles with no LH surge 
detected were excluded from the analysis of the phases of the menstrual cycle. 
Estimated day of ovulation (i.e., presumptive ovulation) was the day after the first positive urinary LH 
test. 
Participants 
Women agreed to provide data to the registry for research purposes. Many of the participants had 
personal interest in monitoring their fertility status for purposes of achieving or avoiding pregnancy. 
Ages of the participants ranged from 20 to 54 years (mean 30.3, SD = 5.9). Participants had varied 
menstrual, pregnancy, and delivery histories. They had a mean of 2.2 pregnancies (SD = 2.2; range 0–9) 
and a mean of 1.9 living children (SD = 1.9; range 0–8). Of the participants, 63 percent had at least one 
pregnancy, and 60 percent had at least one delivery. 
Fertility Monitoring 
Menstrual and presumptive ovulatory data were self-recorded online daily by subjects using an online 
menstrual cycle charting system. Presumptive ovulatory data (urinary LH and conjugated estrone 
[estrone-3-glucuronide]) was obtained by use of the Clear Blue Fertility Monitor manufactured by 
Swiss Precision Diagnostics. Participants tested their first void concentrated urine in the morning from 
day six of the menstrual cycle through the next twenty days or until a positive LH surge was detected. 
Statistical Analysis 
Information from each participant was entered into a data file by a research assistant using the 
seventeenth version of the Statistical Package for Social Scientists. A one-way analysis of variance 
(ANOVA) was used to determine if there was a difference in menstrual cycle length, follicular phase 
length, luteal phase length, and length of menses among the three BMI groups (normal weight = 18.5–
24.9 kg/m2, overweight = 25–29.9 kg/m2, obese = BMI of 30 kg/m2 or greater). A post-hoc Tukey test 
was used to evaluate the differences in menstrual cycle phases between the BMI groups. Pearson's 
Chi-square test and odds ratios were used to determine the likelihood of ovulatory menstrual cycles 
between BMI groups with a statistical probability of p < 0.05. 
Results 
Description of Participants by BMI Group 
Table 1 shows the age, parity, and gravidity status of the 244 participants by BMI level. Of note is that 
42 percent (103/244) of the participants had BMI levels in the overweight or obese categories. There 
was a significant difference in the number of pregnancies among the three levels of BMI (F = 2.23, p < 
0.03) with significantly more living children in the overweight and obese participants (F = 4.23, p < 
0.02; post-hoc comparison p < 0.05). 
Table 1 Age, gravidity, parity, and menstrual cycle parameters by BMI Category 
 
 Normal BMI (N = 141) 
Mean/SD 
Overweight (N = 67) 
Mean/SD 
Obese (N = 36) 
Mean/SD 
Age 29.7/6.2 31.4/5.5 30.8/5.2 
Pregnancies 1.9/2.2 2.6/2.3 2.8/2.3 
Living children 1.6/1.8 2.3/2.1 2.4/1.9 
Menstrual cycle parameters    
Number of cycles N = 1077 N = 642 N = 314 
Length of cycle 29.0/3.8 29.2/3.9 29.4/4.2 
Follicular phase 16.3/3.3 16.6/3.7 16.3/3.4 
Luteal phase 12.7/1.9 12.3/2.1 12.5/2.1 
Menses length 5.2/1.2 5.3/1.5 5.1/1.5 
 
Menstrual Cycle Parameters by BMI Group 
Table 1 also shows the phases of the menstrual cycle by BMI level. One way ANOVA indicated that 
there was a significant difference between groups in length of the luteal phase (F = 4.62, p < 0.01) and 
length of menses (F = 3.03, p < 0.05). Post-hoc testing (Tukey) showed that there was a significant 
difference in luteal phase length between the normal BMI group versus both the overweight and the 
obese groups (p < 0.01) and a marginally significant difference in length of menses (p < 0.06). There 
were no significant differences in length of cycle and length of follicular phase. 
Likelihood of Ovulation 
Chi-square analysis showed that there were significantly more menstrual cycles within the obese and 
overweight BMI groups that did not have a detected LH surge compared to the normal BMI group (Chi-
square = 6.11, p < 0.01). There were only 69 cycles out of 737 without a detected LH surge in the 
normal BMI group (for a percentage of 9.4 percent), 48 cycles without an LH surge in the overweight 
group (10.3 percent), and 44 missing LH surges in the obese group for a percentage of 20.4 percent. 
The combined overweight and obese BMI classification cycles have 92 out of 680 cycles or 13.5 percent 
without a recorded LH surge. The odds ratio between the normal BMI group and the combined obese 
and overweight groups was 0.66 (95 percent CI = 0.48–0.92); that is, the combined obese and 
overweight group was 34 percent less likely to have a positive detected urinary LH surge (see table 1). 
Discussion 
It is noteworthy that the overweight and obese BMI categories had significantly more children than the 
normal weight BMI group. The relationship between higher BMIs and greater number of children can 
possibly be explained by weight gained during pregnancy that is retained. This was a finding observed 
in the SPAWN (Stockholm Pregnancy and Women's Nutrition) Study, which was a long-term study in 
which participants answered questionnaires to include their diet and activity surrounding the time of 
their pregnancy, and with a follow-up fifteen years later.6 However, the results could be confounded 
because the participants in the overweight and obese groups were older than the normal BMI group. 
The data from the older ages and greater number of pregnancies could have affected the outcomes. 
In addition to this, the majority of obese women have normal ovulation,7 which leads us to believe that 
infertility is multifactorial. Our findings show that the luteal phase and length of menses is possibly 
affected by obesity and the overweight and obese participants were less likely to have menstrual cycles 
with a detected LH surge. This may be secondary to anovulation. Anovulation has been proposed as 
the likely mechanism for decreased fecundity in some studies, even in overweight and obese women 
with regular menstrual cycles.8 
Other studies, as discussed, suggest that the causes of these findings are multifactorial. Insulin as it 
relates to insulin resistance and hyperinsulinemia has long been thought to play a major role in 
fertility.9 Hyperinsulinemia stimulates steroidgenesis in the ovarian thecal cells and decreases the 
synthesis of sex-hormone-binding globulin, which may directly contribute to androgen excess.10 Excess 
androgen production can cause premature follicular atresia and impede ovulation.11 Women with 
polycystic ovarian syndrome are examples of women specifically known to have ovulatory dysfunction, 
which is associated with insulin resistance and hyperinsulinemia, decreased sex-hormone-binding 
globulin, and increased testosterone and dihydrotestosterone production.12 Another proposed etiology 
suggests that obesity affects the hypothalamic-pituitary axis via estrogen excess. In obese women, 
there is an excess of free estrogen from peripheral androgen conversion and reduced gonadotropin-
releasing hormone availability. Therefore, abnormal ovarian function results in anovulatory cycles.13 
The ova itself is thought to have a diminished capability for fertilization.14 This current study did show 
an increased frequency of presumed anovulatory menstrual cycles in obese and overweight women 
compared with normal weight women. The poor ovulation and anovulation could result in a shortened 
menses. Furthermore, a shortened luteal phase is also reflective of poor ovulatory response as 
endocrinopathies or the ovulatory process including reduced LH, FSH, and prolactin levels, as well as a 
diminished effect of progesterone on the endometrium have been suggested as causes of defects in 
luteal phase.15 
In addition, obesity is associated with a chronic systemic inflammatory response that also affects 
ovarian function. Oxidative stress and endoplasmic reticulum stress has been noted to damage 
follicular maturation.16 Analysis of ovarian cells and fluid in obese women indicate that there is lipid 
accumulation which is believed to cause inflammation.17 
Of note, the mean values for the length of cycle and length of luteal phase (seen in Table 1) appear to 
be almost identical. Statistically, they are significantly different as there is enough variance between 
the BMI groupings to show a significant change. However, from a clinical perspective, the change is 
small (i.e., less than a day). Therefore it is more important to monitor and look for trends in the 
direction of shorter luteal phases and particularly the finding that there were statistically less 
menstrual cycles with presumed ovulation which is noted by the absence of an LH surge. 
Limitations of the Study 
The main limitation of the study is that the participants were not randomized. They were self-selected 
and chose to participate to monitor their level of fertility for the purposes of achieving or avoiding 
pregnancy. This, however, is also seen as a positive aspect of the study as these women have a 
personal incentive that would contribute to more accurate and regular recording. In addition to this, it 
is not known whether or not the participants have a history of irregular menstrual cycles above the 
average population as women who have more irregular menses would likely be more apt to chart. 
Another limitation is that we were not able to determine the incidence of luteinized unruptured 
follicles during the study as another consideration of anovulation. Documentation supporting the 
failure of these follicles to rupture would require serial ultrasounds of the follicles, which was not 
performed in this study. Furthermore, there might be other reasons for lack of a positive LH test, such 
as improper testing and surges that might occur in the afternoon or evening hours. Twice a day testing 
to increase self-detection of the LH surge is recommended.18 Also, evaluating the LH surge within 
specific BMI ranges in the future may help assess the decreased probability of the LH surge, and 
narrowing the age range of the women in the study may also help, as the number of luteinized 
unruptured follicles increases and duration of the luteal phase shortens in older women. 
Practice Recommendations 
The approach to obese women that present with fertility problems should be seen as potentially 
manageable. Though numerous studies have shown obesity to be closely linked to infertility, ovarian 
function and fecundity improve with weight loss in overweight and obese women.19 An advantage for 
women practicing ongoing fertility monitoring is the ability to postulate about the state of their 
menstrual cycle. Women with higher BMIs would be more likely to have oligomenorrhea or 
amenorrhea and a shorter duration of menses as well as a shorter luteal phase. Since diet, exercise, 
and life-style modification have shown obesity related infertility to be reversible in some cases, 
ongoing charting may show progressive clinical improvements associated with these factors which may 
correlate to improved fecundity. Though not included in our data set, it would be interesting to see if 
there are any correlations with the Billings Ovulation Method and other methods of natural family 
planning that track changes in cervical mucus. 
Testing to exclude other medical conditions for infertility should also be performed. In addition to this, 
weight loss and exercise should be encouraged in women seeking to achieve pregnancy. A dietary 
regimen that allows women to decrease 500 to 1,000 calories per day has been recommended, as well 
as daily physical activity for thirty minutes.20 
Conclusion 
The results of this study point to anovulation as a contributing factor to infertility as indicated by the 
greater percentage of anovulatory cycles among overweight and obese women when compared to 
women with a BMI in the normal range. Anovulation and poor ovulatory function might contribute to 
shortened luteal phases and menses. Further studies are needed to determine the effects of obesity on 
parameters of the menstrual cycle and menstrual cycle functions. 
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